PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Co-proxamol (Dextropropoxyphene hydrochloride/para - Pain

PAD Profile : Co-proxamol (Dextropropoxyphene hydrochloride/para - Pain Important

Keywords :
coproxamol, low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value, analgesia, analgesics
Brand Names Include :
Distalgesic, Cosalgesic, Dolgesic,
Important Information :
No longer licensed because of safety concerns, particularly toxicity in overdose.

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
U
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Guidelines (National)
NHS England - Do not routinely prescribe document - Jun 2019
Policy Statement
Coproxamol - Policy statement - PCN 206-2018 Jan 2018
01 June 2025
Patient resource
Coproxamol - Patient Information - NHS England do not prescribe - Jan-18
01 June 2025
Miscellaneous
SDCCG - Low value medicines implementation resources - Apr 2018
01 April 2021
Information
Co-proxamol - license withdrawal letter from CSM - Jan 2005
Information
Co-proxamol - MHRA Q & A risk v. benefit document - July 2005

Committee Recommendations

Date
Committee Name
Narrative
03 June 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.

If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.

22 January 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network does not recommend the use of co-proxamol. Co-proxamol will be considered BLACK on the traffic light system. Prescribers should: - NOT initiate co-proxamol for any new patient AND - Switch patients taking co-proxamol to an alternative pain medication, in line with NHS England guidance.

Associated BNF Codes

04. Central Nervous System
04.07.01. Non-opioid analgesics and compound preparations
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More